Indication

For the treatment of flares in adult patients with generalised pustular psoriasis (GPP) as monotherapy.

Medicine details

Medicine name:
spesolimab (Spevigo)
SMC ID:
SMC2729
Pharmaceutical company
Boehringer Ingelheim Ltd
BNF chapter
Skin
Submission type
Full
Publication due date:
TBC
SMC meeting date:
TBC
Patient group submission deadline:
TBC